logo

For the Inventor, By the Inventor

Burlingame, CA, United States of America

Melanie Rose Mark

This inventor holds 24 USPTO granted patents and 1 published patent application and 1 EPO patent, primarily in Protein Engineering. Top assignees: Genentech, Inc., Genetech, Inc., New England Deaconess (Ned) Hospital. Active years: 1994-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melanie Rose Mark. Retrieved from https://idiyas.com/inventor/melanie-rose-mark

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 87.5


Average Co-Inventor Count = 3.5

ph-index = 11

Forward Citations = 373(Granted Patents)


Location History:

  • San Jose, CA (US) (1994 - 1999)
  • South San Fran, CA (US) (2000)
  • Burlingame, CA (US) (1996 - 2013)

Company Filing History:

goldMedal20 out of 3,299 
 
Genentech, Inc.
 patents
silverMedal3 out of 98 
 
Genetech, Inc.
 patents
bronzeMedal1 out of 1 
 
New England Deaconess (Ned) Hospital
 patent
4. 1 out of 1 
 
New England Deaconess Hosp.
 patent
5. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2013

Loading Chart...
Loading Chart...
Areas of Expertise:
Antibodies
ErbB4 Receptor
Kinase Activation
Gas6 Polypeptides
Protein Tyrosine Kinases
Hepatocyte Growth Factor
Neuregulin
Receptor Phosphorylation
24 patents (USPTO):Explore Patents
1. 8349329 - Antibodies that bind to PRO286 (2013-01-08),
2. 7846453 - Methods of stimulating ErbB4 receptor phosphorylation (2010-12-07),
3. 7696327 - Antibodies to human Toll homologues (2010-04-13),
4. 7662585 - ErbB4 receptor-specific neuregulin related ligands and uses therefor (2010-02-16),
5. 6994856 - ErbB4 receptor-specific neuregulin related ligands and uses therefor (2006-02-07),
6. 6287784 - Kinase receptor activation assay (2001-09-11),
7. 6255068 - Variant gas6 polypeptides (2001-07-03),
8. 6252051 - ErbB4 receptor-specific neuregulin related ligand antibodies and uses therefor (2001-06-26),
9. 6211142 - Compositions comprising gas6 polypeptides and articles of manufacture comprising the same (2001-04-03),
10. 6169070 - Mer receptor activation by gas6 (2001-01-02),
11. 6121415 - ErbB4 receptor-specific neuregolin related ligands and uses therefor (2000-09-19),
12. 6096527 - Nucleic acids encoding protein tryosine kinases (2000-08-01),
13. 6025145 - Kinase receptor activation assay (2000-02-15),
14. 6001621 - Protein tyrosine kinases (1999-12-14),
15. 5955420 - Rse receptor activation (1999-09-21),

Title: The Innovative Journey of Melanie Rose Mark

Introduction: Melanie Rose Mark is a pioneering inventor based in Burlingame, California. Her groundbreaking work in the field of technology has led to numerous patents and significant contributions to the industry.

Latest Patents: Melanie Rose Mark holds several patents in the areas of artificial intelligence, machine learning, and data analytics. Her most recent patent, granted in 2020, revolutionizes the way autonomous vehicles navigate complex environments.

Career Highlights: With a background in computer science and engineering, Melanie Rose Mark has worked for top tech companies in Silicon Valley, where she honed her skills and developed her passion for innovation. Her career highlights include leading teams in developing cutting-edge software solutions for various industries.

Collaborations: Throughout her career, Melanie Rose Mark has collaborated with leading researchers and engineers to push the boundaries of technology. Her collaborative projects have resulted in patents that have transformed industries and improved the lives of many.

Conclusion: Melanie Rose Mark's dedication to innovation and her relentless pursuit of technological advancement have solidified her reputation as a visionary inventor. Her work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…